Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for anal canal squamous cell carcinoma (JROSG 10-2)
jRCTs041180053Phase 2Completed
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil and mitomycin c in anal squamous cell carcinoma (SCCA). Primary endpoint: 2-year disease-free survival. Started Jan 2014; status: completed.
02
Drugs
fluorouracilmitomycin c
03
Conditions
anal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on jRCTs041180053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180053.